Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension (Q24240794)

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Lisinopril dose-response relationship in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Twenty-Four-Hour Ambulatory Blood Pressure Monitoring and Antihypertensive Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Dose-Finding Study of Cilazapril (Inhibace®) in Patients with Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Dose finding studies with imidapril--a new ACE inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans. Trandolapril Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Effective dose range of enalapril in mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Enalapril in low-renin essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003823.PUB2

Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study

21 January 2018

1 reference

12 December 2020

Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions

1 reference

12 December 2020

Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients

1 reference

12 December 2020

Ketanserin and captopril interaction in the treatment of essential hypertensives

1 reference

12 December 2020

Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition in mild hypertension with concomitant diseases and therapies: an efficacy, safety, and compatibility study of novel design, the Perindopril Therapeutic Safety Study

1 reference

12 December 2020

Increased renal plasma flow in long-term enalapril treatment of hypertension

1 reference

12 December 2020

Efficacy and tolerance of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. Investigator Study Group

1 reference

12 December 2020

Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?

1 reference

12 December 2020

Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group.

1 reference

12 December 2020

Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group

1 reference

12 December 2020

Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II

1 reference

12 December 2020

A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension

1 reference

12 December 2020

Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension

1 reference

12 December 2020

The effect of ramipril on ambulatory blood pressure: a multicenter trial

1 reference

12 December 2020

Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

1 reference

12 December 2020

24-hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: Magnitude and duration of antihypertensive effects

1 reference

12 December 2020

Chronic dose-response curve of enalapril in essential hypertensives. An Italian multicenter study

1 reference

12 December 2020

Antihypertensive Duration of Action of Cilazapril in Patients with Mild to Moderate Essential Hypertension

1 reference

12 December 2020

[2.5 and 5 mg cilazapril once daily in comparison with placebo in hypertension. A comparative study with ambulatory 24-hour monitoring]

1 reference

12 December 2020

Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction

1 reference

12 December 2020

Vasodilator effects of enalapril in patients with arterial hypertension.

1 reference

12 December 2020

Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients

1 reference

12 December 2020

Antihypertensive effect of enalapril as first-step treatment of mild and moderate uncomplicated essential hypertension. Evaluation by two methods of blood pressure measurement

1 reference

12 December 2020

Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination

1 reference

12 December 2020

Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy

1 reference

12 December 2020

Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension

1 reference

12 December 2020

The use of benazepril in hypertensive patients age 55 and over.

1 reference

12 December 2020

Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure

1 reference

12 December 2020

Once-daily treatment of essential hypertension with captopril

1 reference

12 December 2020

The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group

1 reference

12 December 2020

Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension

1 reference

12 December 2020

Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder

1 reference

12 December 2020

Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans

1 reference

12 December 2020

Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women

1 reference

12 December 2020

A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo

1 reference

12 December 2020

Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study

1 reference

12 December 2020

Indomethacin does not attenuate the hypotensive effect of trandolapril

1 reference

12 December 2020

Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Ace inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension

1 reference

12 December 2020

Brazilian multicenter study on efficacy and tolerability of trandolapril in mild-to-moderate essential arterial hypertension. EMBATHE substudy with ambulatory blood pressure monitoring

1 reference

12 December 2020

[Cilazapril in essential hypertension. A placebo-controlled double-blind study to establish the dosage]

1 reference

12 December 2020

Steady-State Pharmacokinetics and Pharmacodynamics of Cilazapril in the Presence and Absence of Cyclopenthiazide

1 reference

12 December 2020

Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial

1 reference

12 December 2020

Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide

1 reference

12 December 2020

Antihypertensive Profiles with Ascending Dose Combinations of Ramipril and Felodipine Er

1 reference

12 December 2020

Dose response and safety of telmisartan in patients with mild to moderate hypertension

1 reference

12 December 2020

[Antihypertensive effect of fosinopril in mild hypertension]

1 reference

12 December 2020

Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension

1 reference

12 December 2020

Dose-response relationship of ramipril in patients with mild-to-moderate hypertension

1 reference

12 December 2020

Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents

1 reference

12 December 2020

Captopril at 50 mg as well as at 100 mg once a day reduces blood pressure for up to 24 h: a double-blind randomized crossover study in mild to moderate hypertensives

1 reference

12 December 2020

Comparative Effects of 2.5 and 5 mg Cilazapril Versus Placebo on Daily Blood Pressure Load

1 reference

12 December 2020

Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Twenty-four hour action of ACE inhibitors

1 reference

12 December 2020

Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension

1 reference

12 December 2020

Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group

1 reference

12 December 2020

Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia

1 reference

12 December 2020

Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril

1 reference

12 December 2020

Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile

1 reference

12 December 2020

Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group

1 reference

12 December 2020

Cilazapril plus hydrochlorothiazide: improved efficacy without reduced safety in mild to moderate hypertension. A double-blind placebo-controlled multicenter study of factorial design

1 reference

12 December 2020

ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension

1 reference

12 December 2020

Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy

1 reference

12 December 2020

Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?

1 reference

12 December 2020

Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group

1 reference

12 December 2020

Quality of life of patients with mild hypertension treated with captopril: a randomized double-blind placebo-controlled clinical trial.

1 reference

12 December 2020

Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension

1 reference

12 December 2020

Fosinopril monotherapy: relationship between blood pressure reduction and time of administration

1 reference

12 December 2020

The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects

1 reference

12 December 2020

A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension

1 reference

12 December 2020

Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension

1 reference

12 December 2020

Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group

1 reference

12 December 2020

Cardiac and hormonal effects of enalapril in hypertension

1 reference

12 December 2020

Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo

1 reference

12 December 2020

A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS)

1 reference

12 December 2020

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

12 December 2020

Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study

1 reference

12 December 2020

The Effect of Cilazapril, a New Angiotensin Converting Enzyme Inhibitor, on Peak and Trough Blood Pressure Measurements in Hypertensive Patients

1 reference

12 December 2020

The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen

1 reference

12 December 2020

Antihypertensive efficacy and tolerability of captopril in the elderly: comparison with hydrochlorothiazide and placebo in a multicentre, double-blind study

1 reference

12 December 2020

ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group

1 reference

12 December 2020

Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group

1 reference

12 December 2020

Dose-response studies with benazepril in mild to moderate hypertension.

1 reference

12 December 2020

Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.

1 reference

12 December 2020

Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension

1 reference

12 December 2020

Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochloride

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril

1 reference

12 December 2020

Treatment of hypertension in the elderly: Effects on blood pressure, heart rate, and physical fitness

1 reference

12 December 2020

Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs

1 reference

12 December 2020

Monotherapy of essential hypertension with a converting-enzyme inhibitor

1 reference

12 December 2020

The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension

1 reference

12 December 2020

Quinapril: a double-blind, placebo-controlled trial in essential hypertension

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects

1 reference

12 December 2020

Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension

1 reference

12 December 2020

A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group

1 reference

12 December 2020

Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril

1 reference

12 December 2020

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising

1 reference

12 December 2020

A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension

1 reference

12 December 2020

Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension

1 reference

12 December 2020

[Effects of captopril on the cerebral blood flow in the hypertensive aged subjects]

1 reference

12 December 2020

Platelet Function During Antihypertensive Treatment with Quinapril, a Novel Angiotensin Converting Enzyme Inhibitor

1 reference

12 December 2020